Immunovant, Inc. (IMVT)

NASDAQ: IMVT · Real-Time Price · USD

15.03

-0.56 (-3.59%)

Sep 23, 2025, 3:24 PM EDT - Market open

Immunovant Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Sep '25 Sep 23, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2018 - 2020
Market Capitalization	2,620	2,903	4,694	2,005	641	1,571	Upgrade
Market Cap Growth	-29.14%	-38.16%	134.16%	212.60%	-59.19%	84.72%	Upgrade
Enterprise Value	2,008	2,528	4,004	1,574	117	1,153	Upgrade
Last Close Price	15.59	17.09	32.31	15.51	5.51	16.04	Upgrade
PB Ratio	4.38	4.10	7.60	5.53	1.37	4.01	Upgrade
P/TBV Ratio	4.28	4.10	7.60	5.53	1.37	4.01	Upgrade
Debt / Equity Ratio	-	0	0	0.00	0.01	0.01	Upgrade
Quick Ratio	11.36	10.42	13.18	8.72	11.38	21.38	Upgrade
Current Ratio	12.32	11.16	13.70	9.34	11.52	21.79	Upgrade
Return on Equity (ROE)	-77.58%	-62.46%	-52.91%	-50.69%	-36.39%	-44.25%	Upgrade
Return on Assets (ROA)	-47.07%	-37.97%	-31.50%	-28.26%	-21.02%	-25.90%	Upgrade
Return on Capital (ROIC)	-51.06%	-41.32%	-34.41%	-31.14%	-22.49%	-27.46%	Upgrade
Earnings Yield	-17.16%	-14.26%	-5.52%	-10.52%	-24.44%	-6.84%	Upgrade
FCF Yield	-16.02%	-12.97%	-4.57%	-9.40%	-16.59%	-5.32%	Upgrade
Buyback Yield / Dilution	-11.11%	-9.76%	-12.21%	-12.21%	-24.98%	-103.14%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q